JPMORGAN CHASE & CO - HELIUS MED TECHNOLOGIES INC ownership

HELIUS MED TECHNOLOGIES INC's ticker is HSDTXXXX and the CUSIP is 42328V504. A total of 29 filers reported holding HELIUS MED TECHNOLOGIES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of HELIUS MED TECHNOLOGIES INC
ValueSharesWeighting
Q4 2020$9,000
+12.5%
22,980
+7.0%
0.00%
Q3 2020$8,0000.0%21,480
+13.2%
0.00%
Q2 2020$8,000
+33.3%
18,980
+5.6%
0.00%
Q1 2020$6,000
-66.7%
17,980
-4.3%
0.00%
Q4 2019$18,000
-40.0%
18,797
+3.2%
0.00%
Q3 2019$30,000
+3.4%
18,206
+317.8%
0.00%
Q1 2019$29,000
-92.8%
4,358
-90.0%
0.00%
Q4 2018$401,000
+170.9%
43,737
+188.8%
0.00%
Q3 2018$148,000
-57.0%
15,146
-58.1%
0.00%
Q2 2018$344,00036,1310.00%
Other shareholders
HELIUS MED TECHNOLOGIES INC shareholders Q4 2019
NameSharesValueWeighting ↓
Rovida Advisors Inc. 1,292,690$1,254,0000.07%
ISTHMUS PARTNERS, LLC 204,829$199,0000.04%
Virtu Financial LLC 85,388$83,0000.01%
Good Life Advisors, LLC 10,811$10,0000.00%
UBS Group AG 19,850$19,0000.00%
Sowell Financial Services LLC 1$00.00%
IFP Advisors, Inc 0$00.00%
BNP PARIBAS FINANCIAL MARKETS 15$15,0000.00%
Advisor Group, Inc. 20$00.00%
US BANCORP \DE\ 500$00.00%
View complete list of HELIUS MED TECHNOLOGIES INC shareholders